GlaxoSmithKline Wants Second Round Bids by Mid-Nov

GlaxoSmithKline is hoping to receive second round bids for a clutch of its non-prescription drugs by mid-November, Reuters reported Wednesday. Bain Capital and Blackstone, which has partnered with Prestige Brands, are seen as the front-runners and most likely participants for the second round of the sale, Reuters wrote.

DealsNorth AmericaUSBriefs